Key Highlights :
Amgen investing more than $600 million in constructing a new Science and Innovation Center in Thousand Oaks, California.
The center marries automation and digital prowess to drive research on next-generation medicines.
Breaks ground in Q3 2025, creating hundreds of American jobs.
Key Background :
Amgen, the largest biotech company in the world, has increased its US footprint through the years with monumental investments in research and production. Amgen's expansion of a new center for innovation on the corporate campus in California is also one of its larger bets of investing locally in science infrastructure.
The new center is designed to convene researchers, engineers, and scientists to create solutions to some of the world's most intractable health challenges in an interdisciplinary environment. With more automation and digital capabilities built into it, the center will speed up drug discovery by minimizing hours wasted on new drugs.
The facility is merely one of Amgen's colossal investments of American capital in recent years. The company already is expanding its footprint in Central Ohio with a $900 million manufacturing investment and constructing a $1 billion building in Holly Springs, North Carolina. Cumulatively, the projects reflect Amgen's double-barreled strategy for developing advanced research capabilities and introducing production centers to meet global demand.
Policymaking reforms in the US have influenced the company's strategic initiatives to some extent as well. Tax reform and tax benefits introduced through new legislations have given a boost to a healthier investment climate for science and technology. Amgen has explicitly translated such policies into the key drivers of its megaprojects.
Its economic contribution is also significant. Once work on the project starts in 2025, the project would generate tens of high-paying biotech, automation, and engineering jobs. It not only drives the local Thousand Oaks economy but also repositions the U.S. as a global leader in life science innovation.
Finally, Amgen's newest Science and Innovation Center represents its commitment to push beyond biotechnology boundaries, employing new tools as it joins open research collaborations to bring life-saving medicines to patients around the globe.
About the Author
Kevin Smith
Kevin Smith is a Managing Editor at World Care Magazine.